<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Anderson EMS Pocket Medic</title>
    <link rel="icon" href="../favicon.ico" type="image/png" />
    <link rel="stylesheet" href="../Trauma.css" />
    <link rel="stylesheet" href="TXASOG.css" />
  </head>
  <body>
    <a href="../../../index.html" class="header-link">
      <div class="header">
        <h1>Anderson EMS Pocket Medic</h1>
      </div>
    </a>

    <div class="MainBody">
      <h2>Tranexamic Acid (TXA)<br>
      -SOG-</h2>

      <div class="InitialBody">
        <p>
          <span class="centerBold">Patients who meet the administration criteria for TXA (Epistaxis withstanding) will also
          meet the <a href="../TriageAlgo/TriageAlgo.html" class="working-link" title="Triage Algo SOG">REGION 4 TRAUMA TRIAGE ALGORITHYM </a>criteria for patients who are
          designated to be transported to the closest Level 1 Trauma Center. Consider air medical
          services as a means to reduce transport times to the closest trauma center. </span>
        </p>
        <p>
          <span class="greenCenter">Criteria</span><br>
          1. Age &gt; 18.<br><br>
          2. Blunt or penetrating trauma<br><br>
          3. Time of injury less than <strong>3 hours (180 minutes)</strong>. Prefer &lt; 60 minutes from initial traumatic injury.<br><br>
          4. <strong>All trauma patients with ongoing significant hemorrhage or who are considered at risk for significant
          hemorrhage when either or both of the following criteria are present:<br><br>
          <span class="Indention">
          a. SBP &lt;90 mmHg<br><br>
          b. Pulse Rate ≥ 110 bpm</strong>
          </span>

        </p>
        <h3 class="PARAMEDIC">Paramedic/PHRN</h3>
        <p>
          1. <a href="../InitialSources/Initial.html" class="working-link" title="Initial Trauma Care SOG">INITIAL TRAUMA CARE</a><br><br>
          2. Refer to <a href="../../AdultMedical/ShockSources/Shock.html" class="working-link" title="Shock SOG">SHOCK</a>
           and 
           <a href="../ExtremityInjuries/ExtremityInjuries.html" class="working-link" title="Extremity Trauma SOG">EXTREMITY TRAUMA / EXTERNAL HEMORRHAGE MANAGEMENT</a> 
           Protocol.<br><br>
          3. Ideally, obtain at least 1 dedicated IV/IO line for TXA, and a second large bore IV/IO for continuous IV fluid
          administration. If unable to establish two lines, TXA may be administered via a secondary infusion (piggyback) 
          while infusing isotonic solution for the treatment of shock.<br><br>
          4. Administer <strong><a href="../../../DrugMaterial/TXAFolder/txa.html" class="working-link" title="TXA Med Page">TXA</a> 1 gram IV/IO over 10 minutes</strong>.<br><br>
          <span class="Indention">
              <i>*According to the manufacturer, TXA should be given via a dedicated line.*</i><br><br>
              a. Mix <strong>1 gram/10mL vial in 100mL NS and administer over 10 minutes IV</strong> at a wide open rate.<br><br>
              b. If unable to be given IV/IO, 
              <a href="../../../DrugMaterial/TXAFolder/txa.html" class="working-link" title="TXA Med Page">TXA</a> <strong>1 gram/10mL</strong> may given deep 
              <strong>IM</strong> utilizing two injection sites by
              splitting the standard dose into two <strong>(500mg/5mL) doses</strong>.
          </span><br>
          5. During initial report to the receiving facility, and at transition of care, report the time of injury and time of 
          <a href="../../../DrugMaterial/TXAFolder/txa.html" class="working-link" title="TXA Med Page">TXA</a>
          loading dose.

        </p>
        <p>
          <strong>PEARLS</strong><br><br>
          • Tranexamic acid is an antifibrinolytic drug that is used for the management of severe hemorrhage (external/
          internal)<br><br>
          • Tranexamic acid mechanism of action is to slow the clot breakdown process<br><br>
          • Consideration should be given to the administration of (TXA) so that it occurs during the early stages of
          treatment and transport.<br><br>
          • Do not delay more urgent critical resuscitation interventions when administering (TXA.)<br><br>
          • Hypotension has been associated with an infusion rate greater than 100mg/min<br><br>
          • Should not be used for any patient with a known hypersensitivity to (TXA)<br><br>
          • Should not be used for patients with known severe renal failure<br><br>
          • Should not be used for patents with a history of thromboembolism disorder.<br><br>
          • Patients receiving (TXA) ideally should be transported to trauma centers which are capable of administering
          additional doses of (TXA).<br><br>
        </p>

        <table class="EndTable">
          <thead>
            <tr>
              <th><strong>KEY DOCUMENTATION ELEMENTS </strong></th>
              <th><strong>PERTINENT ASSESSMENT FINDINGS </strong></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                • Criteria for (TXA) administration<br><br>
                • Administration of (TXA) dose over 10 minutes<br><br>
                • No known history of (TXA) sensitivity<br><br>
                • Documentation of adverse reaction

              </td>
              <td>
                • Blunt or penetrating trauma findings on physical
                exam<br><br>
                • Assessment for adverse reaction (hypotension,
                anaphylaxis) secondary to administration of (TXA)
              </td>
            </tr>
          </tbody>
        </table>
        <table class="QMTable">
          <tr>
            <td><strong>QUALITY METRICS</strong><br /><br /></td>
          </tr>
          <tr>
            <td>
            • Scene time for trauma patients<br><br>
            • Appropriate transport of trauma patients to Trauma Center<br><br>
            • Criteria for TXA administration were met
            </td>
          </tr>
        </table>
      </div>
    </div>
    <script src="https://code.jquery.com/jquery-3.7.1.min.js"></script>
    <script src="TXASOG.js"></script>
  </body>
  <footer class="footer">
    <p>&copy; 2025 LukiSoft. All rights reserved.</p>
  </footer>
</html>
 